Equities

Apollomics Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
APLM:NAQ

Apollomics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)6.00
  • Today's Change0.26 / 4.53%
  • Shares traded6.68k
  • 1 Year change-69.77%
  • Beta0.9212
Data delayed at least 15 minutes, as of Jul 15 2025 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2024, cash reserves at Apollomics Inc fell by 22.29m. However, Cash Flow from Investing totalled 5.98m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 28.74m for operations while cash generated from financing totalled 468.00k.
Cash flow per share-54.66
Price/Cash flow per share--
Book value per share4.41
Tangible book value per share2.84
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.